{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:57:56Z","timestamp":1790866676585,"version":"4.1.0"},"reference-count":136,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>Hypertrophic cardiomyopathy is a common heritable heart disease. The disease is genetically, anatomically, and clinically heterogeneous. Hypertrophic cardiomyopathy is inherited in an autosomal dominant pattern but has allelic heterogeneity, incomplete penetrance, and variable expressivity. Beyond family screening, clinical evaluation for hypertrophic cardiomyopathy is often prompted by identification of symptoms or detection of a heart murmur, additionally, abnormal electrocardiogram or imaging results performed for another reason can provide evidence. Evaluation should include obtaining a patient\u2019s history, a physical examination, cardiac imaging, and, often, genetic testing. Prognosis is variable; major causes of morbidity and mortality are caused by sudden cardiac death, heart failure, and atrial fibrillation with associated stroke risk. An understanding of the pathogenesis at the genetic, cellular, and individual levels helps clinicians to implement appropriate screening, recognise clinical manifestations, and improve the treatment of patients with hypertrophic cardiomyopathy. The understanding of this condition is evolving, with recent advances and insights into its pathogenesis, refinement of risk stratification, and use of artificial intelligence in screening, diagnosis, and prognostication.<\/jats:p>","DOI":"10.1136\/bmjmed-2025-002433","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:26:17Z","timestamp":1790864777000},"page":"e002433","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenesis, screening, and diagnosis of hypertrophic cardiomyopathy"],"prefix":"10.1136","volume":"5","author":[{"given":"Kendra M","family":"Gilreath","sequence":"first","affiliation":[{"name":"Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell B","family":"Newman","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R","family":"Ommen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B","family":"Geske","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100107001167000_5.1.e002433.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.01.019"},{"key":"2026100107001167000_5.1.e002433.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001250"},{"key":"2026100107001167000_5.1.e002433.3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028974","article-title":"Is hypertrophic cardiomyopathy always a familial and inherited disease?","volume":"12","author":"Bonaventura","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026100107001167000_5.1.e002433.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.05.061"},{"key":"2026100107001167000_5.1.e002433.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2022.03.012"},{"key":"2026100107001167000_5.1.e002433.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.742395"},{"key":"2026100107001167000_5.1.e002433.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)33671-8"},{"key":"2026100107001167000_5.1.e002433.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)33660-3"},{"key":"2026100107001167000_5.1.e002433.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026"},{"key":"2026100107001167000_5.1.e002433.10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High\u2010Risk Population","volume":"3","author":"Siontis","year":"2014","journal-title":"JAHA"},{"key":"2026100107001167000_5.1.e002433.11","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.316"},{"key":"2026100107001167000_5.1.e002433.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.08.041"},{"key":"2026100107001167000_5.1.e002433.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.112.963363"},{"key":"2026100107001167000_5.1.e002433.14","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-011-9266-2"},{"key":"2026100107001167000_5.1.e002433.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.002"},{"key":"2026100107001167000_5.1.e002433.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae421"},{"key":"2026100107001167000_5.1.e002433.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.223842"},{"key":"2026100107001167000_5.1.e002433.18","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.3390\/ijms22168933","article-title":"Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction","volume":"22","author":"Chou","year":"2021","journal-title":"IJMS"},{"key":"2026100107001167000_5.1.e002433.19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030682","article-title":"Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future","volume":"12","author":"Abbas","year":"2024","journal-title":"Biomedicines"},{"key":"2026100107001167000_5.1.e002433.20","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-316798"},{"key":"2026100107001167000_5.1.e002433.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203422","article-title":"Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure","volume":"13","author":"Vanninen","year":"2018","journal-title":"PLoS ONE"},{"key":"2026100107001167000_5.1.e002433.22","doi-asserted-by":"crossref","first-page":"104079","DOI":"10.1016\/j.ejmg.2020.104079","article-title":"The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals","volume":"63","author":"Salazar-Mendiguch\u00eda","year":"2020","journal-title":"Eur J Med Genet"},{"key":"2026100107001167000_5.1.e002433.23","first-page":"3461","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes","volume":"38","author":"Walsh","year":"2017","journal-title":"Eur Heart J"},{"key":"2026100107001167000_5.1.e002433.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02094-5"},{"key":"2026100107001167000_5.1.e002433.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00764-0"},{"key":"2026100107001167000_5.1.e002433.26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042195","article-title":"Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy","volume":"23","author":"U\u0161aj","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026100107001167000_5.1.e002433.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.011"},{"key":"2026100107001167000_5.1.e002433.28","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.065987"},{"key":"2026100107001167000_5.1.e002433.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.82.1.106"},{"key":"2026100107001167000_5.1.e002433.30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fphys.2020.00516","article-title":"Hypertrophic and Dilated Cardiomyopathy-Associated Troponin T Mutations R130C and \u0394K210 Oppositely Affect Length-Dependent Calcium Sensitivity of Force Generation","volume":"11","author":"Groen","year":"2020","journal-title":"Front Physiol"},{"key":"2026100107001167000_5.1.e002433.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318346"},{"key":"2026100107001167000_5.1.e002433.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311059"},{"key":"2026100107001167000_5.1.e002433.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309348"},{"key":"2026100107001167000_5.1.e002433.34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115061"},{"key":"2026100107001167000_5.1.e002433.35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.013556","article-title":"Left Atrial Reservoir Strain-Based Left Ventricular Diastolic Function Grading and Incident Heart Failure in Hypertrophic Cardiomyopathy","volume":"15","author":"Lee","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.echo.2019.01.007","article-title":"Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients","volume":"32","author":"Vasquez","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.37","doi-asserted-by":"crossref","DOI":"10.31083\/RCM46198","article-title":"Left Atrial Reservoir Strain in Cardiovascular and Systemic Disease: Advances and Clinical Applications From Physiology to Practice","volume":"26","author":"Sonaglioni","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"2026100107001167000_5.1.e002433.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2025.03.011"},{"key":"2026100107001167000_5.1.e002433.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.02.014"},{"key":"2026100107001167000_5.1.e002433.40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.echo.2024.06.011","article-title":"Unmasking Obstruction in Hypertrophic Cardiomyopathy With Postprandial Resting and Treadmill Stress Echocardiography","volume":"37","author":"Massera","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.075"},{"key":"2026100107001167000_5.1.e002433.42","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.166777"},{"key":"2026100107001167000_5.1.e002433.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2024.02.010"},{"key":"2026100107001167000_5.1.e002433.44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.echo.2018.10.011","article-title":"Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy","volume":"32","author":"Hang","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.echo.2021.03.011","article-title":"Echocardiographic Characteristics of Severe Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy","volume":"34","author":"Jain","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.46","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.echo.2024.05.002","article-title":"Mitral Geometry on the Mechanism of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy","volume":"37","author":"Lin","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.echo.2022.09.018","article-title":"The Role of the Submitral Apparatus in Hypertrophic Obstructive Cardiomyopathy","volume":"36","author":"Tao","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.10.032"},{"key":"2026100107001167000_5.1.e002433.49","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-019-0761-3","article-title":"Magnetic resonance imaging of the papillary muscles of the left ventricle: normal anatomy, variants, and abnormalities","volume":"10","author":"Rajiah","year":"2019","journal-title":"Insights Imaging"},{"key":"2026100107001167000_5.1.e002433.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.02.033"},{"key":"2026100107001167000_5.1.e002433.51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","article-title":"Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy: A Clinical-Pathological Study of 30 Explanted Hearts","volume":"9","author":"Galati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026100107001167000_5.1.e002433.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00164-7"},{"key":"2026100107001167000_5.1.e002433.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.11.017"},{"key":"2026100107001167000_5.1.e002433.54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ehjci\/jead177","article-title":"Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction","volume":"24","author":"Choi","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmg.2025.08.019","article-title":"Feature Tracking-Derived Global Longitudinal Strain Enhances Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy","volume":"19","author":"Ma","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.56","first-page":"101330","article-title":"Prevalence, Management, and Comorbidities of Adults With Atrial Fibrillation in the United States, 2019 to 2023","volume":"3","author":"Oltman","year":"2024","journal-title":"JACC: Advances"},{"key":"2026100107001167000_5.1.e002433.57","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.8.858"},{"key":"2026100107001167000_5.1.e002433.58","doi-asserted-by":"crossref","unstructured":"Zipes DP , Wellens HJJ . Sudden cardiac death. In: Smeets J , Doevendans PA , Josephson ME , et al ., eds. Professor hein JJ wellens: 33 years of cardiology and arrhythmology. Dordrecht: Springer Netherlands, 2000: 621\u201345.","DOI":"10.1007\/978-94-011-4110-9_60"},{"key":"2026100107001167000_5.1.e002433.59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021332"},{"key":"2026100107001167000_5.1.e002433.60","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur362"},{"key":"2026100107001167000_5.1.e002433.61","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2024.38","article-title":"Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?","volume":"11","author":"Rajan","year":"2025","journal-title":"Card Fail Rev"},{"key":"2026100107001167000_5.1.e002433.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.02.031"},{"key":"2026100107001167000_5.1.e002433.63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36642"},{"key":"2026100107001167000_5.1.e002433.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2013.11.006"},{"key":"2026100107001167000_5.1.e002433.65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2022.03.028","article-title":"Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis","volume":"357","author":"Mascia","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026100107001167000_5.1.e002433.66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2022.11.030","article-title":"Syncope in hypertrophic cardiomyopathy: Explaining the unexplained","volume":"373","author":"Geske","year":"2023","journal-title":"Int J Cardiol"},{"key":"2026100107001167000_5.1.e002433.67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2022.06.051","article-title":"Explaining unexplained syncope in hypertrophic cardiomyopathy: A clinical dilemma","volume":"363","author":"Geske","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026100107001167000_5.1.e002433.68","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.798314"},{"key":"2026100107001167000_5.1.e002433.69","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2000.16659"},{"key":"2026100107001167000_5.1.e002433.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.072"},{"key":"2026100107001167000_5.1.e002433.71","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp121"},{"key":"2026100107001167000_5.1.e002433.72","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3390\/jcm11216560","article-title":"Microvascular Dysfunction in Hypertrophic Cardiomyopathy","volume":"11","author":"Pelliccia","year":"2022","journal-title":"JCM"},{"key":"2026100107001167000_5.1.e002433.73","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00392-023-02328-8","article-title":"Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management","volume":"113","author":"Li","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"2026100107001167000_5.1.e002433.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.02.040"},{"key":"2026100107001167000_5.1.e002433.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.063"},{"key":"2026100107001167000_5.1.e002433.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2018.03.004"},{"key":"2026100107001167000_5.1.e002433.77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.echo.2021.10.016","article-title":"Repetitive Squat-to-Stand Provocation of Dynamic Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy","volume":"35","author":"Peng","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"2026100107001167000_5.1.e002433.78","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.3.402"},{"key":"2026100107001167000_5.1.e002433.79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2019.06.042","article-title":"Surgical septal myectomy for relief of dynamic obstruction in Anderson-Fabry Disease","volume":"292","author":"Meghji","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026100107001167000_5.1.e002433.80","first-page":"103946","article-title":"Management of Cardiac Amyloidosis With Concomitant Left Ventricular Outflow Tract Obstruction","volume":"30","author":"Gupta","year":"2025","journal-title":"JACC: Case Reports"},{"key":"2026100107001167000_5.1.e002433.81","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjcard.2023.10.081","article-title":"Role of Imaging in the Diagnosis, Evaluation, and Management of Hypertrophic Cardiomyopathy","volume":"212S","author":"Abraham","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026100107001167000_5.1.e002433.82","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ehjci\/jeac099","article-title":"Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance","volume":"23","author":"Huurman","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.83","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2016.11.010","article-title":"Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography","volume":"119","author":"Bois","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026100107001167000_5.1.e002433.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.03.035"},{"key":"2026100107001167000_5.1.e002433.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2011.11.021"},{"key":"2026100107001167000_5.1.e002433.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.10.032"},{"key":"2026100107001167000_5.1.e002433.87","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026100107001167000_5.1.e002433.88","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf200"},{"key":"2026100107001167000_5.1.e002433.89","doi-asserted-by":"crossref","first-page":"132951","DOI":"10.1016\/j.ijcard.2024.132951","article-title":"Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals","volume":"422","author":"Schoonvelde","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026100107001167000_5.1.e002433.90","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp306"},{"key":"2026100107001167000_5.1.e002433.91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2026100107001167000_5.1.e002433.92","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-82-4-521"},{"key":"2026100107001167000_5.1.e002433.93","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2012-091874"},{"key":"2026100107001167000_5.1.e002433.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.12.061"},{"key":"2026100107001167000_5.1.e002433.95","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.5.1596"},{"key":"2026100107001167000_5.1.e002433.96","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2008.054726"},{"key":"2026100107001167000_5.1.e002433.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.07.070"},{"key":"2026100107001167000_5.1.e002433.98","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jcmg.2023.04.002","article-title":"Refining the Prognostic Value of LGE in Hypertrophic Cardiomyopathy: Presence, Extent, and Location-What\u2019s Next?","volume":"16","author":"Mahrholdt","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.99","first-page":"1163","article-title":"Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy","volume":"16","author":"Yang","year":"2023","journal-title":"JACC: Cardiovascular Imaging"},{"key":"2026100107001167000_5.1.e002433.100","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s11886-022-01778-2","article-title":"Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies","volume":"24","author":"Pieroni","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2026100107001167000_5.1.e002433.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.06.038"},{"key":"2026100107001167000_5.1.e002433.102","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.097997"},{"key":"2026100107001167000_5.1.e002433.103","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl041"},{"key":"2026100107001167000_5.1.e002433.104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026100107001167000_5.1.e002433.105","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht439"},{"key":"2026100107001167000_5.1.e002433.106","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.cjca.2019.05.004","article-title":"Variable and Limited Predictive Value of the European Society of Cardiology Hypertrophic Cardiomyopathy Sudden-Death Risk Model: A Meta-analysis","volume":"35","author":"Wang","year":"2019","journal-title":"Canadian Journal of Cardiology"},{"key":"2026100107001167000_5.1.e002433.107","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026100107001167000_5.1.e002433.108","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.033200"},{"key":"2026100107001167000_5.1.e002433.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.071"},{"key":"2026100107001167000_5.1.e002433.110","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007094"},{"key":"2026100107001167000_5.1.e002433.111","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/ehjci\/jeaa423","article-title":"Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study","volume":"22","author":"Greulich","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.010"},{"key":"2026100107001167000_5.1.e002433.113","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000331"},{"key":"2026100107001167000_5.1.e002433.114","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s10554-025-03518-3","article-title":"The influence of genotype on the phenotype and prognosis of patients with hypertrophic cardiomyopathy","volume":"41","author":"Conde","year":"2025","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026100107001167000_5.1.e002433.115","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17629","article-title":"Prognosis of patients with familial hypertrophic cardiomyopathy: A single-center cohort study with ten-year follow-up by propensity score matching analysis","volume":"9","author":"He","year":"2023","journal-title":"Heliyon"},{"key":"2026100107001167000_5.1.e002433.116","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.hrthm.2025.06.015","article-title":"Counterpoint: Sudden cardiac death in competitive student-athletes with hypertrophic cardiomyopathy: From one-size-fits-all to personalization","volume":"23","author":"Jorstad","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026100107001167000_5.1.e002433.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.07.035"},{"key":"2026100107001167000_5.1.e002433.118","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurheartj\/ehaf770","article-title":"Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation","volume":"47","author":"Zampieri","year":"2026","journal-title":"Eur Heart J"},{"key":"2026100107001167000_5.1.e002433.119","article-title":"Healthcare access, symptom burden, and psychological impact in hypertrophic cardiomyopathy: a multinational patient-driven survey","volume":"27","author":"Tsenov","year":"2025","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2026100107001167000_5.1.e002433.120","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi325"},{"key":"2026100107001167000_5.1.e002433.121","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000239"},{"key":"2026100107001167000_5.1.e002433.122","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/eurheartj\/ehae919","article-title":"High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial","volume":"46","author":"Basu","year":"2025","journal-title":"Eur Heart J"},{"key":"2026100107001167000_5.1.e002433.123","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026100107001167000_5.1.e002433.124","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"2026100107001167000_5.1.e002433.125","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-018-0218-8"},{"key":"2026100107001167000_5.1.e002433.126","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077274","article-title":"Current management of hypertrophic cardiomyopathy","volume":"389","author":"Sikand","year":"2025","journal-title":"BMJ"},{"key":"2026100107001167000_5.1.e002433.127","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.gim.2023.100797","article-title":"Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model","volume":"25","author":"Christensen","year":"2023","journal-title":"Genetics in Medicine"},{"key":"2026100107001167000_5.1.e002433.128","first-page":"106","article-title":"Using a neural network to diagnose the hypertrophic portions of hypertrophic cardiomyopathy","volume":"15","author":"Ouyang","year":"1998","journal-title":"MD Comput"},{"key":"2026100107001167000_5.1.e002433.129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/ehjdh\/ztaf086","article-title":"Artificial intelligence applications in hypertrophic cardiomyopathy: turns and loopholes","volume":"6","author":"Panichella","year":"2025","journal-title":"Eur Heart J Digit Health"},{"key":"2026100107001167000_5.1.e002433.130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14134718","article-title":"Advanced Diagnosis of Hypertrophic Cardiomyopathy with AI-ECG and Differences Based on Ethnicity and HCM Subtype","volume":"14","author":"Lewontin","year":"2025","journal-title":"J Clin Med"},{"key":"2026100107001167000_5.1.e002433.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.030"},{"key":"2026100107001167000_5.1.e002433.132","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.hrtlng.2025.09.012","article-title":"AI-driven ECG diagnostics: A game-changer for hypertrophic cardiomyopathy. A systematic review and diagnostic test accuracy meta-analysis","volume":"75","author":"\u0141ajczak","year":"2026","journal-title":"Heart Lung"},{"key":"2026100107001167000_5.1.e002433.133","doi-asserted-by":"crossref","unstructured":"Karra N , Klempfner Y , Fiman M , et al . Diagnosis of hypertrophic cardiomyopathy by artificial intelligence using standard transthoracic echocardiography. Eur Heart J 2024;45. doi:10.1093\/eurheartj\/ehae666.1003","DOI":"10.1093\/eurheartj\/ehae666.1003"},{"key":"2026100107001167000_5.1.e002433.134","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012667","article-title":"Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence","volume":"18","author":"Hillis","year":"2025","journal-title":"Circ Heart Fail"},{"key":"2026100107001167000_5.1.e002433.135","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacc.2024.12.010","article-title":"Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel","volume":"85","author":"Hespe","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026100107001167000_5.1.e002433.136","doi-asserted-by":"crossref","unstructured":"Maleszewski JJ , Burke AP , Veinot JP , et al . Disorders of the heart and blood vessels. In: American registry of pathology. 2023. Available: https:\/\/arppress.org\/books\/book\/62\/Disorders-of-the-Heart-and-Blood-Vessels","DOI":"10.55418\/9781933477299"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2025-002433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:26:27Z","timestamp":1790864787000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2025-002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,10,1]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjmed-2025-002433"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2025-002433","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}